GB201908511D0 - Hydroxamate compounds - Google Patents
Hydroxamate compoundsInfo
- Publication number
- GB201908511D0 GB201908511D0 GBGB1908511.7A GB201908511A GB201908511D0 GB 201908511 D0 GB201908511 D0 GB 201908511D0 GB 201908511 A GB201908511 A GB 201908511A GB 201908511 D0 GB201908511 D0 GB 201908511D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- hydroxamate compounds
- hydroxamate
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1908511.7A GB201908511D0 (en) | 2019-06-13 | 2019-06-13 | Hydroxamate compounds |
PCT/GB2020/051432 WO2020260857A1 (en) | 2019-06-13 | 2020-06-12 | Hydroxamate compounds as antagonists of the adenosine a2a receptor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1908511.7A GB201908511D0 (en) | 2019-06-13 | 2019-06-13 | Hydroxamate compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201908511D0 true GB201908511D0 (en) | 2019-07-31 |
Family
ID=67432163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1908511.7A Ceased GB201908511D0 (en) | 2019-06-13 | 2019-06-13 | Hydroxamate compounds |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201908511D0 (en) |
WO (1) | WO2020260857A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023201267A1 (en) | 2022-04-13 | 2023-10-19 | Gilead Sciences, Inc. | Combination therapy for treating trop-2 expressing cancers |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW427993B (en) | 1993-09-09 | 2001-04-01 | Fujisawa Pharmaceutical Co | New cephem compounds |
BRPI0409366A (en) | 2003-04-10 | 2006-04-25 | Hoffmann La Roche | pyrimidine compounds |
WO2007034277A1 (en) | 2005-09-19 | 2007-03-29 | Pfizer Products Inc. | Aryl substituted imidazo [4,5-c] pyridine compounds as c3a receptor antagonists |
BRPI0720522A2 (en) | 2006-12-22 | 2014-01-07 | Actelion Pharmaceuticals Ltd | 5,6,7,8-TETRAHYDROIMIDAZO [1,5-A] PIRAZINE DERIVATIVE COMPOUND AND USE OF THIS OR ONE OF ITS PHARMACEUTICALLY ACCEPTABLE SALTS. |
AU2009225869B2 (en) * | 2008-03-18 | 2014-01-23 | Merck Sharp & Dohme Llc | Substituted 4-hydroxypyrimidine-5-carboxamides |
TW201102390A (en) | 2009-03-31 | 2011-01-16 | Arqule Inc | Substituted pyrazolo-pyrimidine compounds |
KR20120089463A (en) | 2009-08-20 | 2012-08-10 | 노파르티스 아게 | Heterocyclic oxime compounds |
GB201001070D0 (en) | 2010-01-22 | 2010-03-10 | St George's Hospital Medical School | Theraputic compounds and their use |
RS61242B1 (en) | 2012-09-04 | 2021-01-29 | Shanghai hengrui pharmaceutical co ltd | Imidazoline derivatives, preparation methods thereof, and their applications in medicine |
CN103664908A (en) * | 2013-12-10 | 2014-03-26 | 苏州大学 | Aminopyrimidine heterocyclic compound having adenosine receptor antagonizing activity |
TWI704148B (en) | 2016-10-10 | 2020-09-11 | 美商亞雷生物製藥股份有限公司 | Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors |
GB201721751D0 (en) * | 2017-12-22 | 2018-02-07 | Adorx Therapeutics Ltd | Compounds |
-
2019
- 2019-06-13 GB GBGB1908511.7A patent/GB201908511D0/en not_active Ceased
-
2020
- 2020-06-12 WO PCT/GB2020/051432 patent/WO2020260857A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2020260857A1 (en) | 2020-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL292753A (en) | Compounds | |
IL289463A (en) | Gipr-agonist compounds | |
GB201905721D0 (en) | Compounds | |
GB201916915D0 (en) | Compounds | |
GB201910305D0 (en) | Compounds | |
GB201908536D0 (en) | Compounds | |
GB201908171D0 (en) | Compounds | |
GB201908511D0 (en) | Hydroxamate compounds | |
IL291322A (en) | Acrylamide compounds | |
GB201910304D0 (en) | Compounds | |
GB201908095D0 (en) | Carboxy-MIDA-boronate compounds | |
GB201919205D0 (en) | Compounds | |
GB201918761D0 (en) | Compounds | |
GB201918424D0 (en) | Compounds | |
GB201917895D0 (en) | Compounds | |
GB201917893D0 (en) | Compounds | |
GB201917891D0 (en) | Compounds | |
GB201916847D0 (en) | Compounds | |
GB201916597D0 (en) | Compounds | |
GB201916595D0 (en) | Compounds | |
GB201916572D0 (en) | Compounds | |
GB201916142D0 (en) | Compounds | |
GB201914208D0 (en) | Compounds | |
GB201913633D0 (en) | Compounds | |
GB201913541D0 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |